Nanomedicines for infectious diseases

Thumbnail Image

Files

dube_nanomedicines_2019.pdf (1.11 MB)

Date

2019

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Springer Nature

Abstract

Infectious diseases continue to pose a significant threat to global health. Over 200 infectious diseases are currently known to man. Fortunately, only a handful are responsible for significant morbidity and mortality. HIV/AIDS, tuberculosis (TB) and malaria top the list of deadly infectious diseases, and worldwide, these three diseases combined, are responsible for over 3 million deaths every year (1). Outbreaks of infectious diseases are also not uncommon and examples in recent history include the Ebola virus, Zika virus and Avian flu outbreaks which originated in West Africa, South America and Asia, respectively, before spreading to other parts of the world (2–4). This further emphasizes the global concern over infectious diseases.

Description

Keywords

Nanomedicine, Infectious diseases, Tuberculosis

Citation

Dube, A. Nanomedicines for Infectious Diseases. Pharm Res 36, 63 (2019). https://doi.org/10.1007/s11095-019-2603-x

URI

https://doi.org/10.1007/s11095-019-2603-x
 http://hdl.handle.net/10566/5239

Collections

Research Articles (School of Pharmacy)